Spinout Active LTD

Company profile

Pragmatic Genomics Limited

UK company 13539725, incorporated on 30 July 2021.

Pragmatic Genomics Ltd

Pragmatic Genomics Limited is a spin-off of Queen Mary University of London. We provide software and analysis services to genomics researchers and clinical geneticists working in biomedical, agricultural and environmental organizations.

Company number
13539725
Incorporated
30 Jul 2021
Companies House status
Active

Company identity

Browse spinouts
Founded / incorporated
30 July 2021

Company number 13539725

Verify at Companies House
Legal name
PRAGMATIC GENOMICS LIMITED
Company type
LTD
Region
Unknown
Registered address
Unknown
Insolvency history
No

Latest accounts

Financial period: 1 Dec 2023 to 30 Nov 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
0

Company events

Reference milestones and recent Companies House filing stream events.

2 events
01 Aug
2026

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzUzNjUyNDI3MmFkaXF6a2N4

Published 01 Aug 2026 13:28

30 Jul
2021

Incorporated

Inception

Company registered at Companies House

Spinout profile

4 entries

Company description

Pragmatic Genomics develops a range of data science software and provides data analysis, specialising in genomics data.

Software as a service company - for our bioinformatics genome analysis software

Project impact

Customers in private (biotech, agroindustry), public and third sectors.

Pragmatic Genomics
2021
Pragmatic Genomics
2021
Pragmatic Genomics
2021
PRAGMATIC GENOMICS LIMITED
2021

Public funding

1 award
First funded
2023
Funded years
2023
Age at first award
1 years

Projects

2023 Grant for R&D Lead participant

Transforming SequenceServer: unlocking new revenue opportunities by incorporating collaborative tools and molecular cloning capabilities

1 Jun 2023 to 30 Nov 2023

Awarded
£49,972
Total cost £49,972

The commoditisation and decentralisation of DNA sequencing has completely changed biological research, with similar changes underway in biological engineering across agroindustry, biotech, pharma, diagnostics and treatment of disease. A key challenge that accompanies the resulting opportunities is for staff scientists to make sense of the spectacular amou...

Product types

Grant for R&D